$30,000 Cancer Drug ‘Low in Benefits’
James V. Caruso plans to begin marketing a drug named Folotyn in January for T-cell lymphoma, a rare and usually aggressive blood cancer for which he claims patients have “no options.” A one month treatment using Folotyn costs: $30,000, according…
